Breath of Life Pharma, Ltd. — Form D

Breath of Life Pharma, Ltd. of REVADIM, L3, a company, filed a Form D exempt-offering notice with the SEC on 2018-06-15. The offering totals $12.0M, of which $9.7M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2018-06-15
• Form: D
• Accession: 0001742928-18-000002
• Industry: Pharmaceuticals
• Exemptions: 06c
• Total offering: $12.0M
• Amount sold: $9.7M
• Remaining: $2.3M
• Minimum investment: $10K
• Investors: 21
• Date of first sale: 2018-05-21
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-314690

Issuer

• Name: Breath of Life Pharma, Ltd.
• CIK: 0001742928
• Entity type: Corporation
• Jurisdiction: ISRAEL
• Incorporated: 2017
• Address: INDUSTRIAL AREA, REVADIM, L3, 7982000
• Phone: 2129810355

Officers, directors & promoters (2)

More

• CIK 1742928 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search